helicobacter-pylori

Documents about helicobacter-pylori

• The Efficacy of the 7 Days Tailored Therapy as 2nd Rescue Therapy for Eradication of H. Pylori Infection#160402ClinicalTrials.gov
• Spatial Study of TLR4, TLR5 and TLR9 in Gastric Premalignant Lesions Before and After Helicobacter pylori Eradication#267185Repositorio USS
• Use of WeChat-based patient-doctor interaction improves patient experience of Helicobacter pylori treatment: a randomized controlled trial.#281133NCBI PubMed Central
• Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for First-line Treatment of Hp Infection#387176ClinicalTrials.gov
• Measurement and Analysis of Gas Composition in Digestive Tract#830106ClinicalTrials.gov
• The Safety and Tolerability, Pharmacokinetics of TNP-2092 Capsules in Combination With Rabeprazole Sodium Enteric-coated Tablets#880846ClinicalTrials.gov
• The Efficacy of 10-day or 14-day Course of Bismuth-containing Quadruple Therapy:A Randomized Clinical Trial#915551ClinicalTrials.gov
• Integrative bioinformatics and machine learning identify shared molecular mechanisms and diagnostic biomarkers between Helicobacter pylori infection and atrial fibrillation.#3746NCBI PubMed Central
• Advances in Helicobacter pylori-mediated oncogenic signaling pathways in gastric cancer: From pathological evolution to clinical application prospects (Review).#402569NCBI PubMed Central
• Nasal Endoscopic Screening and Risk Assessment for Early Gastric Cancer#992635ClinicalTrials.gov
• A study of clinical and endoscopic findings of dyspepsia patients.#319519Zenodo (CERN)
• N-Doped carbon quantum dot-based ratiometric fluorescent nanosensor platforms for detection of gastric cancer-associated <i>Helicobacter pylori</i> genes#419897Aperta
• Gastric Cancer Precursor Lesions (GCPL) Study#802174ClinicalTrials.gov
• Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy, Vonoprazan-amoxicillin Dual Therapy and Proton Pump Inhibitor-based Standard Triple Therapy for Hp Eradication#454047ClinicalTrials.gov
• Additive Effect of Endonase on Eradication Rate of Second Line Therapy for HP Infection#860789ClinicalTrials.gov
• H. Pylori Eradication on Healing of Iatrogenic Gastric Ulcer by Endoscopic Mucosal Resection#889593ClinicalTrials.gov
• A Phase 1 Study to Evaluate PK Profile of Multiple Oral Administrations of TNP-2092 Capsules in Healthy Subjects#890345ClinicalTrials.gov
• H. Pylori Testing for Patients With Non-specific Upper Abdominal Pain in the Emergency Department#871826ClinicalTrials.gov
• A Relevance Study Between the Result of Clinical Drug Intervention and Next-generation Sequencing Technology Focused on Refractory Helicobacter Pylori Infection#143599ClinicalTrials.gov
• Dignosis of gastric adenocarcinoma using a scoring system: Combined assay of serological markers of Helicobacter pylori infection, pepsinogen I and gastrin#383777CiNii
• Monitoring the disulfide bond formation of a cysteine-rich repeat protein from Helicobacter pylori in the periplasm of Escherichia coli#403856DataCite
• Manuka honey as a multifunctional therapeutic against Helicobacter pylori: from chemical profiling to in vitro potency and in vivo gastroprotective efficacy.#437281NCBI PubMed Central
• White Light Endoscopy and Magnifying Endoscopy in Assessing the Status of Hp Infection#825594ClinicalTrials.gov
• The research progress of the synergistic effect of Epstein-Barr virus and Helicobacter pylori infection in the occurrence and development of gastric cancer.#457508NCBI PubMed Central
• Knowledge, beliefs, perceived barriers, and previous upper gastrointestinal endoscopy use regarding Helicobacter pylori and gastric cancer prevention among community residents: a cross-sectional study.#613328NCBI PubMed Central
• Usefulness of Serum Pepsinogen and Gastrin as the Predictive Biomarker of Atrophic Gastritis, Intestinal Metaplasia and Gastric Cancer in Korea#879294ClinicalTrials.gov
• The Efficacy and Safety of Ilaprazole/Doxycycline-based Bismuth-containing Quadruple Therapy on Hp Infected Duodenal Ulcers#184897ClinicalTrials.gov
• Síntese de derivados de adenina com potencial atividade antitumoral e antimicrobiana contra a Helicobacter pylori#368502Repositório da UFES
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effect of TNP-2198 Capsules After Single Oral Dose in Healthy Participants#889631ClinicalTrials.gov
• Screening for Stomach Diseases and Colorectal Neoplasms With the Fecal Testing#1047301ClinicalTrials.gov
• The exposome perspective : environmental and infectious agents as drivers of cancer disparities in low- and middle-income countries#687086University of Pretoria Repository
• Efficacy and Safety of Vonoprazan-Based Dual Therapies With Different Antibiotics Versus Bismuth-Containing Quadruple Therapy for Helicobacter pylori Eradication: A Prospective, Four-Arm, Randomized Controlled Trial.#193659NCBI PubMed Central
• Concurrent overexpression of serum p53 mutation related with Helicobacter pylori infection#648498Spiral
• Psychoemotional Status and Functional Gastrointestinal Disorders#830219ClinicalTrials.gov
• A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring#904776ClinicalTrials.gov
• Additional file 1 of Synergistic anti-Helicobacter pylori efficacy of a molecularly identified Limosilactobacillus fermentum isolate in combination with multiple antibiotics#339902Figshare
• Premedication With N-acetylcysteine and Simethicone to Improve Mucosal Visualization in Elective Upper Endoscopy#979787ClinicalTrials.gov